Stay updated on Ibrutinib & PD-1 Blockade in High Risk CLL Clinical Trial

Sign up to get notified when there's something new on the Ibrutinib & PD-1 Blockade in High Risk CLL Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Ibrutinib & PD-1 Blockade in High Risk CLL Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The page now shows Revision: v3.5.4, replacing the previous v3.5.3 label. This indicates a backend/template update to the study record display without changing substantive study details.
    Difference
    0.1%
    Check dated 2026-05-15T15:13:25.000Z thumbnail image
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    Change Detected
    Summary
    The page’s footer “Revision” version was updated from v3.5.2 to v3.5.3, reflecting a backend/site release rather than a change to the study record content.
    Difference
    0.1%
    Check dated 2026-04-24T05:50:00.000Z thumbnail image
  5. Check
    29 days ago
    Change Detected
    Summary
    Revision: v3.5.2 updated from v3.5.0. No visible changes to study details or page content.
    Difference
    0.1%
    Check dated 2026-04-17T02:17:59.000Z thumbnail image
  6. Check
    44 days ago
    Change Detected
    Summary
    Added the keyword/MeSH term 'B-cell chronic lymphocytic leukemia.' Added a new resource link to the Genetic and Rare Diseases Information Center.
    Difference
    0.2%
    Check dated 2026-04-02T15:27:15.000Z thumbnail image
  7. Check
    58 days ago
    Change Detected
    Summary
    Revision tag updated to v3.5.0, replacing v3.4.3. This is a UI/version change and does not alter study details or eligibility.
    Difference
    0.1%
    Check dated 2026-03-19T03:29:05.000Z thumbnail image
  8. Check
    65 days ago
    Change Detected
    Summary
    Footer revision updated from v3.4.2 to v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-11T20:12:47.000Z thumbnail image

Stay in the know with updates to Ibrutinib & PD-1 Blockade in High Risk CLL Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Ibrutinib & PD-1 Blockade in High Risk CLL Clinical Trial page.